Part 2 - A phase II study of Anti-PD1 (nivolumab) therapy as pre- and post-operative therapy in metastatic renal cell cancer (ADAPTeR) - 100098

Spotlight
Video

Part 2 - A phase II study of Anti-PD1 (nivolumab) therapy as pre- and post-operative therapy in metastatic renal cell cancer (ADAPTeR)

kidneycancer has 684 videos Subscribe Here

Loading........
Description: Samra Turajlic The Royal Marsden NHS Foundation Trust, London, UK discusses the second part of A phase II study of Anti-PD1 (nivolumab) therapy as pre- and post-operative therapy in metastatic renal cell cancer (ADAPTeR) at the Kidney Cancer International Symposium 2019 in Dubrovnik, Croatia
Shared By : kidneycancer
Posted on : 04/02/19
Added : 2 months ago
Category : Kidney Cancer



Recommended

Nothing found.